Suppr超能文献

伽玛刀手术治疗海绵窦海绵状血管瘤。

Gamma knife surgery for cavernous hemangiomas in the cavernous sinus.

机构信息

Department of Neurosurgery, Neurological Institute, Taipei Veterans General Hospital; and School of Medicine, National Yang Ming University, Taipei, Taiwan.

出版信息

Neurosurgery. 2010 Sep;67(3):611-6; discussion 616. doi: 10.1227/01.NEU.0000378026.23116.E6.

Abstract

BACKGROUND

Cavernous hemangioma in the cavernous sinus (CS) is a rare vascular tumor. Direct microsurgical approach usually results in massive hemorrhage. Radiosurgery has emerged as a treatment alternative to microsurgery.

OBJECTIVE

To further investigate the role of Gamma Knife surgery (GKS) in treating CS hemangiomas.

METHODS

This was a retrospective analysis of 7 patients with CS hemangiomas treated by GKS between 1993 and 2008. Data from 84 CS meningiomas treated during the same period were also analyzed for comparison. The patients underwent follow-up magnetic resonance imaging at 6-month intervals. Data on clinical and imaging changes after radiosurgery were analyzed.

RESULTS

Six months after GKS, magnetic resonance imaging revealed an average of 72% tumor volume reduction (range, 56%-83%). After 1 year, tumor volume decreased 80% (range, 69%-90%) compared with the pre-GKS volume. Three patients had > 5 years of follow-up, which showed the tumor volume further decreased by 90% of the original size. The average tumor volume reduction was 82%. In contrast, tumor volume reduction of the 84 cavernous sinus meningiomas after GKS was only 29% (P < .001 by Mann-Whitney U test). Before treatment, 6 patients had various degrees of ophthalmoplegia. After GKS, 5 improved markedly within 6 months. Two patients who suffered from poor vision improved after radiosurgery.

CONCLUSION

GKS is an effective and safe treatment modality for CS hemangiomas with long-term treatment effect. Considering the high risks involved in microsurgery, GKS may serve as the primary treatment choice for CS hemangiomas.

摘要

背景

海绵窦内海绵状血管瘤是一种罕见的血管肿瘤。直接显微手术通常会导致大量出血。放射外科已成为显微手术的替代治疗方法。

目的

进一步探讨伽玛刀手术(GKS)治疗海绵窦血管瘤的作用。

方法

这是对 1993 年至 2008 年间接受 GKS 治疗的 7 例海绵窦血管瘤患者进行的回顾性分析。同时还分析了同期接受治疗的 84 例海绵窦脑膜瘤患者的数据进行比较。患者接受了 6 个月间隔的随访磁共振成像。分析放射治疗后临床和影像学变化的数据。

结果

GKS 后 6 个月,磁共振成像显示平均肿瘤体积缩小 72%(范围,56%-83%)。与 GKS 前体积相比,1 年后肿瘤体积缩小 80%(范围,69%-90%)。3 例患者随访> 5 年,显示肿瘤体积进一步缩小了原始大小的 90%。平均肿瘤体积减少了 82%。相比之下,GKS 治疗后 84 例海绵窦脑膜瘤的肿瘤体积缩小仅为 29%(Mann-Whitney U 检验,P<0.001)。治疗前,6 例患者有不同程度的眼肌麻痹。GKS 后,5 例患者在 6 个月内明显改善。2 例视力不佳的患者在放射治疗后得到改善。

结论

GKS 是治疗海绵窦血管瘤的有效且安全的方法,具有长期疗效。考虑到显微手术的高风险,GKS 可能成为海绵窦血管瘤的主要治疗选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验